Research

We write fundamental equity research on ASX-listed companies, in which we explain the science and the financial case. Every report is free to read.

Coverage areas

Therapeutics

Diagnostics

Medical technology

Digital health

In-depth coverage that develops over time – not just a single report.

Our analytical framework

Bridge Life Sciences covers ASX-listed life science companies across therapeutics, diagnostics, medical technology and digital health, from preclinical development through to commercialisation.

Each report covers the company's financial position and funding requirements, its evidence base and regulatory pathway, and its commercial opportunity. We also provide a detailed explanation of our valuation methodology, including with key assumptions, catalysts and risks.

View the latest research reports

General information only. See Legal and Disclaimer.